Colorectal cancer (CRC) remains a major global health burden, with emerging evidence implicating gut and oral microbiome dysbiosis in its pathogenesis. This comparative observational study aimed to ...

It has been a volatile year for BioNTech (BNTX +2.93%), an mRNA-based vaccine specialist. The company's financial results ...

Current US FDA-cleared stool-based colorectal cancer (CRC) molecular screening tests include fecal immunochemical tests (FIT) for occult blood detection; however, integration with nucleic acid-based ...

Patients who underwent an appendectomy for acute appendicitis had a significantly lower subsequent risk of colorectal cancer ...

Colorectal cancer (CRC) is emerging as a critical health concern, particularly due to a concerning rise in diagnoses among younger individuals. Colorectal cancer (CRC), developing in the colon or ...

Researchers often use antibodies to detect specific molecules or biological markers because they are remarkably precise at ...

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal ...

WovenX Health, a Chicago-based specialty care platform, today announced a GI procedure partner network spanning all 50 states and Washington, D.C., supporting the launch of a national colorectal ...

With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine’s Section of Digestive Diseases are redoubling their efforts to spread the word ...

Metastatic colorectal cancer (mCRC) continues to increase among patients 45 and younger. Their longer survival and different ...

It can indicate a more advanced stage of the disease or can be a sign of a different medical condition.

Phase 1 findings reinforce the potential of WRN inhibition as a synthetic lethal approach to treating MSI-high cancers Among ...